Evaluation of Renvela in Patients With Chronic Kidney Disease Not On Dialysis And Hyperphosphatemia In China

Investigational Site Number 1560003, Beijing

Investigational Site Number 1560021, Shenyang

Investigational Site Number 1560038, Shenyang

Investigational Site Number 1560019, Dalian

Investigational Site Number 1560015, Changchun

Investigational Site Number 1560002, Shanghai

Investigational Site Number 1560007, Shanghai

Investigational Site Number 1560017, Nanjing

Investigational Site Number 1560035, Xuzhou

Investigational Site Number 1560012, Tianjin

Investigational Site Number 1560014, Tianjin

Investigational Site Number 1560004, Nanchang

Investigational Site Number 1560005, Nanchang

Investigational Site Number 1560032, Nanchang

Investigational Site Number 1560013, Fuzhou

Investigational Site Number 1560020, Xiamen

Investigational Site Number 1560018, Xiamen

Investigational Site Number 1560030, Chongqing

Investigational Site Number 1560011, Changsha

Investigational Site Number 1560036, Hengyang

Investigational Site Number 1560039, Hengyang

Investigational Site Number 1560010, Wuhan

Investigational Site Number 1560001, Guangzhou

Investigational Site Number 1560027, Guangzhou

Investigational Site Number 1560016, Zhanjiang

Investigational Site Number 1560031, Haikou

Investigational Site Number 1560008, Xi'an

Investigational Site Number 1560006, Lanzhou

Investigational Site Number 1560024, Yinchuan

Investigational Site Number 1560026, Cangzhou

Investigational Site Number 1560037, Guilin

Investigational Site Number 1560033, Kunming

Investigational Site Number 1560034, Kunming

Investigational Site Number 1560029, Nanning

Investigational Site Number 1560028, Ningbo

Investigational Site Number 1560023, Hohhot

Investigational Site Number 1560025, Shijiazhuang

Investigational Site Number 1560022, Taiyuan